bokomslag High-Throughput RNAi Screening
Kropp & själ

High-Throughput RNAi Screening

David O Azorsa Shilpi Arora

Inbunden

2729:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 7-11 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

Andra format:

  • 262 sidor
  • 2016
High-throughput RNAi screening remains one of the most widely used technologies to perform target identification and validation studies in an unbiased manner. These assays are equally important for research and development across academic, biotech, and pharmaceutical industries. The success of these screening efforts is dependent on robust methodologies to perform these screens. In High-Throughput RNAi Screening: Methods and Protocols, expert researchers in the field share protocols and methods for performing high-throughput RNAi (HT-RNAi) screens. These include the use of various RNAi platforms and delivery methods in mammalian and non-mammalian systems, whole organism and cell models, and various applications, such as drug sensitizer identification. Finally, the book examines the latest advancements in the fields of assay development, library screening, data analysis, and hit selection. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Cutting-edge and thorough, High-Throughput RNAi Screening: Methods and Protocols provides a comprehensive source of protocols and other necessary information to make robust and successful assays possible for all who wish to apply HT-RNAi in their research.
  • Författare: David O Azorsa, Shilpi Arora
  • Illustratör: Bibliographie 9 schwarz-weiße und 44 farbige Abbildungen
  • Format: Inbunden
  • ISBN: 9781493963355
  • Språk: Engelska
  • Antal sidor: 262
  • Utgivningsdatum: 2016-08-31
  • Förlag: Humana Press Inc.